NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 149 filers reported holding NEKTAR THERAPEUTICS in Q2 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $94,509 | +2.4% | 158,680 | -1.1% | 0.00% | – |
| Q2 2023 | $92,268 | -18.2% | 160,413 | 0.0% | 0.00% | – |
| Q1 2023 | $112,753 | -69.4% | 160,413 | -1.6% | 0.00% | -100.0% |
| Q4 2022 | $368,584 | +39.6% | 163,091 | +96.3% | 0.00% | 0.0% |
| Q3 2022 | $264,000 | +1930.8% | 83,081 | +2290.1% | 0.00% | – |
| Q2 2022 | $13,000 | -79.7% | 3,476 | -71.5% | 0.00% | – |
| Q1 2022 | $64,000 | -66.8% | 12,214 | -14.8% | 0.00% | – |
| Q4 2021 | $193,000 | -43.7% | 14,332 | -25.1% | 0.00% | -100.0% |
| Q3 2021 | $343,000 | -2.3% | 19,136 | -6.7% | 0.00% | 0.0% |
| Q2 2021 | $351,000 | -42.7% | 20,514 | -33.2% | 0.00% | 0.0% |
| Q1 2021 | $613,000 | -19.6% | 30,729 | -31.1% | 0.00% | -50.0% |
| Q4 2020 | $762,000 | +0.4% | 44,611 | -2.7% | 0.00% | 0.0% |
| Q3 2020 | $759,000 | -35.2% | 45,856 | -9.5% | 0.00% | -33.3% |
| Q2 2020 | $1,172,000 | +6068.4% | 50,675 | +4592.1% | 0.00% | – |
| Q1 2020 | $19,000 | +216.7% | 1,080 | +239.6% | 0.00% | – |
| Q4 2019 | $6,000 | -91.4% | 318 | -91.8% | 0.00% | – |
| Q3 2019 | $70,000 | -48.5% | 3,893 | 0.0% | 0.00% | – |
| Q2 2019 | $136,000 | +6.2% | 3,893 | 0.0% | 0.00% | – |
| Q1 2019 | $128,000 | +6.7% | 3,893 | +8.9% | 0.00% | – |
| Q4 2018 | $120,000 | -60.7% | 3,575 | -28.8% | 0.00% | -100.0% |
| Q3 2018 | $305,000 | -87.0% | 5,018 | -89.5% | 0.00% | -80.0% |
| Q2 2018 | $2,339,000 | -67.8% | 47,934 | -30.0% | 0.01% | -58.3% |
| Q1 2018 | $7,259,000 | +4.9% | 68,449 | -40.2% | 0.01% | 0.0% |
| Q4 2017 | $6,922,000 | +127.2% | 114,416 | -9.9% | 0.01% | +140.0% |
| Q3 2017 | $3,046,000 | +17.8% | 126,961 | -4.0% | 0.01% | 0.0% |
| Q2 2017 | $2,585,000 | +21.1% | 132,207 | +45.3% | 0.01% | +25.0% |
| Q1 2017 | $2,135,000 | +118.1% | 90,965 | +13.3% | 0.00% | +100.0% |
| Q4 2016 | $979,000 | – | 80,290 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 598,400 | $10,083,000 | 3.98% |
| Opus Point Partners Management, LLC | 348,583 | $5,874,000 | 3.88% |
| Camber Capital Management LP | 3,500,000 | $58,975,000 | 3.81% |
| 1492 Capital Management LLC | 180,601 | $3,043,000 | 2.21% |
| Virtus ETF Advisers LLC | 38,260 | $645,000 | 1.77% |
| Cormorant Asset Management, LP | 765,156 | $12,893,000 | 1.54% |
| Rhenman & Partners Asset Management AB | 581,000 | $9,790,000 | 1.48% |
| Granahan Investment Management | 2,082,155 | $35,084,000 | 1.21% |
| BRIDGER MANAGEMENT, LLC | 1,563,862 | $26,351,000 | 0.87% |
| RICE HALL JAMES & ASSOCIATES, LLC | 899,531 | $15,157,000 | 0.87% |